by Croft SL. Trans R Soc Trop Med Hyg, October 2005, 99 Suppl 1:S9-14.
Summary: Major changes in research and development (R&D) for drugs to treat tropical and neglected diseases have occurred in the past five years. Public-private partnerships have proved that they can move compounds quickly through the R&D pipeline. The challenge is to ensure that the products are delivered to the people who need them and to ensure that scientists in endemic countries are involved in the whole process.
